First Mercantile Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

First Mercantile Trust’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$170K	Sell	6,370 -435	-6%	-$11.7K	0.02%	470
2021 Q2	$210K	Sell	6,805 -378	-5%	-$11.6K	0.02%	431
2021 Q1	$188K	Buy	+7,183	New	+$201K	0.02%	458
2020 Q2	–	Sell	-2,468	Closed	-$44K	–	949
2020 Q1	$44K	Buy	2,468 +301	+14%	+$6.33K	0.01%	723
2019 Q4	$51K	Sell	2,167 -6	-0.3%	-$146	0.01%	789
2019 Q3	$60K	Buy	2,173 +520	+31%	+$15.4K	0.01%	791
2019 Q2	$55K	Sell	1,653 -12	-0.7%	-$411	0.01%	749
2019 Q1	$58K	Buy	1,665 +190	+13%	+$7.07K	0.01%	761
2018 Q4	$49K	Buy	1,475 +275	+23%	+$11.8K	0.01%	780
2018 Q3	$60K	Buy	+1,200	New	+$59.3K	0.01%	770
2018 Q1	–	Sell	-5,864	Closed	-$234K	–	826
2017 Q4	$234K	Sell	5,864 -837	-12%	-$33.1K	0.05%	493
2017 Q3	$268K	Buy	+6,701	New	+$290K	0.05%	476
2015 Q4	–	Sell	-460	Closed	-$6K	–	977
2015 Q3	$6K	Buy	+460	New	+$8.55K	﹤0.01%	958
2014 Q3	–	Sell	-4,380	Closed	-$48K	–	1202
2014 Q2	$48K	Hold	4,380	–	–	﹤0.01%	960
2014 Q1	$39K	Buy	+4,380	New	+$40.3K	﹤0.01%	1106

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

First Mercantile Trust's SUPN Position: Q3 2021 in Review

First Mercantile Trust reduced its Supernus Pharmaceuticals (SUPN) stake by 6.4% in Q3 2021, selling an estimated $11.7K and leaving 6,370 shares worth $170K. The position accounts for 0.02% of the portfolio, ranked #470.

First Mercantile Trust first reported a position in SUPN in Q1 2014 and has held it in 15 quarters since. The position peaked at $268K in Q3 2017. 223 funds tracked by Wall St. Rank hold SUPN as of Q3 2021.

First Mercantile Trust held 6,370 shares of Supernus Pharmaceuticals worth $170K as of Q3 2021.
First Mercantile Trust sold 435 Supernus Pharmaceuticals shares in Q3 2021, an estimated $11.7K.
Supernus Pharmaceuticals made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #470 holding.
First Mercantile Trust first reported a position in Supernus Pharmaceuticals in Q1 2014 and has held it in 15 quarters since.
First Mercantile Trust's Supernus Pharmaceuticals position peaked at $268K in Q3 2017.
223 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.